{ "resourceType" : "Bundle", "id" : "c97d5d89-4467-4c1e-9954-9d1e1d1d46e2", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-bundle"] }, "type" : "collection", "entry" : [{ "fullUrl" : "http://fhir.epl.bag.admin.ch/CHIDMP/MedicinalProductDefinition/Triogen-250mg-Capsule", "resource" : { "resourceType" : "MedicinalProductDefinition", "id" : "Triogen-250mg-Capsule", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-medicinalproductdefinition"] }, "text" : { "status" : "extensions", "div" : "

Generated Narrative: MedicinalProductDefinition Triogen-250mg-Capsule

Profile: MedicinalProductDefinition

CH SMC - Authorized Dose Form: Capsule, hard

identifier: Medical Product Identifier/CH-01100828-0674310010000

indication:

Zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen.

\n

legalStatusOfSupply: Medicinal product subject to medical or veterinary prescription (B)

additionalMonitoringIndicator: No Warning

pediatricUseIndicator: Authorised for the treatment in children

classification: trientine, NA KAS art. 12 para. 5 TPLO, Synthetic, Originator product, 07. STOFFWECHSEL, 07.99. Varia

attachedDocument:

name

productName: Triogen 250 mg, Kapseln

type: FOPH Medicinal Product Name

Usages

-CountryLanguage
*SwitzerlandGerman (Switzerland)
" }, "extension" : [{ "url" : "http://fhir.ch/ig/ch-epl/StructureDefinition/authorizedDoseForm", "valueCodeableConcept" : { "coding" : [{ "system" : "http://standardterms.edqm.eu", "code" : "10210000", "display" : "Capsule, hard" }] } }], "identifier" : [{ "system" : "http://fhir.ch/ig/ch-epl/sid/mpid", "value" : "CH-01100828-0674310010000" }], "indication" : "Zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen.", "legalStatusOfSupply" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-legal-status-of-supply", "code" : "756005022003", "display" : "Medicinal product subject to medical or veterinary prescription (B)" }] }, "additionalMonitoringIndicator" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-additional-monitoring-indicator", "code" : "756005001003", "display" : "No Warning" }] }, "pediatricUseIndicator" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-pediatric-use-indicator", "code" : "756005003001", "display" : "Authorised for the treatment in children" }] }, "classification" : [{ "coding" : [{ "system" : "http://www.whocc.no/atc", "code" : "A16AX12" }] }, { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-category", "code" : "756005021001", "display" : "NA KAS art. 12 para. 5 TPLO" }] }, { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-therapeuticproductcode", "code" : "756005004001", "display" : "Synthetic" }] }, { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-product-type", "code" : "756001003002", "display" : "Originator product" }] }, { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-index-therapeuticus", "code" : "070000", "display" : "07. STOFFWECHSEL" }] }, { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-index-therapeuticus", "code" : "079900", "display" : "07.99. Varia" }] }], "attachedDocument" : [{ "reference" : "DocumentReference/DocRef-FI-Triogen" }, { "reference" : "DocumentReference/DocRef-PI-Triogen" }], "name" : [{ "productName" : "Triogen 250 mg, Kapseln", "type" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-medicinal-product-name-type", "code" : "FOPH", "display" : "FOPH Medicinal Product Name" }] }, "usage" : [{ "country" : { "coding" : [{ "system" : "urn:iso:std:iso:3166", "code" : "CH", "display" : "Switzerland" }] }, "language" : { "coding" : [{ "system" : "urn:ietf:bcp:47", "code" : "de-CH", "display" : "German (Switzerland)" }] } }] }] } }, { "fullUrl" : "http://fhir.epl.bag.admin.ch/CHIDMP/DocumentReference/DocRef-FI-Triogen", "resource" : { "resourceType" : "DocumentReference", "id" : "DocRef-FI-Triogen", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-documentreference"] }, "language" : "de-CH", "text" : { "status" : "generated", "div" : "

Generated Narrative: DocumentReference DocRef-FI-Triogen

Language: de-CH

Profile: DocumentReference

identifier: Application / Assessment Tracking Number/123456789-initial submission-Example-qrs-123

status: Current

type: Fachinformation

date: 2019-12-01 00:00:00+0000

content

Attachments

-Url
*https://swissmedicinfo.ch/showTextAccepted.aspx?textType=FI&lang=DE&authNr=67431&supportMultipleResults=1
" }, "identifier" : [{ "system" : "http://fhir.ch/ig/ch-epl/sid/attno", "value" : "123456789-initial submission-Example-qrs-123" }], "status" : "current", "type" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-attached-document-type", "code" : "756005007001", "display" : "Fachinformation" }] }, "date" : "2019-12-01T00:00:00Z", "content" : [{ "attachment" : { "url" : "https://swissmedicinfo.ch/showTextAccepted.aspx?textType=FI&lang=DE&authNr=67431&supportMultipleResults=1" } }] } }, { "fullUrl" : "http://fhir.epl.bag.admin.ch/CHIDMP/DocumentReference/DocRef-PI-Triogen", "resource" : { "resourceType" : "DocumentReference", "id" : "DocRef-PI-Triogen", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-documentreference"] }, "language" : "de-CH", "text" : { "status" : "generated", "div" : "

Generated Narrative: DocumentReference DocRef-PI-Triogen

Language: de-CH

Profile: DocumentReference

identifier: Application / Assessment Tracking Number/123456789-initial submission-Example-qrs-321

status: Current

type: Patienteninformation

date: 2019-12-01 00:00:00+0000

content

Attachments

-Url
*https://swissmedicinfo.ch/showTextAccepted.aspx?textType=PI&lang=DE&authNr=67431&supportMultipleResults=1
" }, "identifier" : [{ "system" : "http://fhir.ch/ig/ch-epl/sid/attno", "value" : "123456789-initial submission-Example-qrs-321" }], "status" : "current", "type" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-attached-document-type", "code" : "756005007002", "display" : "Patienteninformation" }] }, "date" : "2019-12-01T00:00:00Z", "content" : [{ "attachment" : { "url" : "https://swissmedicinfo.ch/showTextAccepted.aspx?textType=PI&lang=DE&authNr=67431&supportMultipleResults=1" } }] } }, { "fullUrl" : "http://fhir.epl.bag.admin.ch/CHIDMP/RegulatedAuthorization/MA-6743101", "resource" : { "resourceType" : "RegulatedAuthorization", "id" : "MA-6743101", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-regulatedauthorization"] }, "text" : { "status" : "generated", "div" : "

Generated Narrative: RegulatedAuthorization MA-6743101

Profile: RegulatedAuthorization

identifier: Marketing Authorisation Number/6743101

subject: MedicinalProductDefinition: extension = Capsule, hard; identifier = http://fhir.ch/ig/ch-epl/sid/mpid#Medical Product Identifier#CH-01100828-0674310010000; indication = Zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Authorised for the treatment in children; classification = trientine,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product,07. STOFFWECHSEL,07.99. Varia

type: Marketing Authorisation

region: Switzerland

status: valid

statusDate: 2020-05-28

holder: Organization IDEOGEN AG

regulator: Organization Swissmedic Swiss Agency for Therapeutic Products

Generated Narrative: Organization #holder-Ideogen-AG

Profile: Organization

identifier: Swissmedic Location Identifier/01100828, LOC Identifier/100012910, GLN Identifier/7601001403062

name: IDEOGEN AG

Generated Narrative: Organization #regulator-SMC

Profile: Organization

identifier: LOC Identifier/100010911, GLN Identifier/7601001398511

name: Swissmedic Swiss Agency for Therapeutic Products

" }, "contained" : [{ "resourceType" : "Organization", "id" : "holder-Ideogen-AG", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-organization"] }, "identifier" : [{ "system" : "https://www.swissmedic.ch/fhir/identifier/locations", "value" : "01100828" }, { "system" : "https://spor.ema.europa.eu/v1/locations", "value" : "100012910" }, { "system" : "urn:oid:2.51.1.3", "value" : "7601001403062" }], "name" : "IDEOGEN AG" }, { "resourceType" : "Organization", "id" : "regulator-SMC", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-organization"] }, "identifier" : [{ "system" : "https://spor.ema.europa.eu/v1/locations", "value" : "100010911" }, { "system" : "urn:oid:2.51.1.3", "value" : "7601001398511" }], "name" : "Swissmedic Swiss Agency for Therapeutic Products" }], "identifier" : [{ "system" : "http://fhir.ch/ig/ch-epl/sid/authno", "value" : "6743101" }], "subject" : [{ "reference" : "MedicinalProductDefinition/Triogen-250mg-Capsule" }], "type" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type", "code" : "756000002001", "display" : "Marketing Authorisation" }] }, "region" : [{ "coding" : [{ "system" : "urn:iso:std:iso:3166", "code" : "CH", "display" : "Switzerland" }] }], "status" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-status", "code" : "756005023007", "display" : "valid" }] }, "statusDate" : "2020-05-28", "holder" : { "reference" : "#holder-Ideogen-AG" }, "regulator" : { "reference" : "#regulator-SMC" } } }, { "fullUrl" : "http://fhir.epl.bag.admin.ch/CHIDMP/PackagedProductDefinition/PMP-Triogen-250mg-Capsule", "resource" : { "resourceType" : "PackagedProductDefinition", "id" : "PMP-Triogen-250mg-Capsule", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-packagedproductdefinition"] }, "text" : { "status" : "generated", "div" : "

Generated Narrative: PackagedProductDefinition PMP-Triogen-250mg-Capsule

Profile: PackagedProductDefinition

identifier: Clinical Product Identifier/CH-01100828-0674310010000-0001

packageFor: MedicinalProductDefinition: extension = Capsule, hard; identifier = http://fhir.ch/ig/ch-epl/sid/mpid#Medical Product Identifier#CH-01100828-0674310010000; indication = Zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Authorised for the treatment in children; classification = trientine,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product,07. STOFFWECHSEL,07.99. Varia

containedItemQuantity: 100 Capsule (Details: EDQM - Standard Terms code15012000 = 'Capsule')

description:

TRIOGEN Kaps 250 mg Ds 100 Stk

\n

LegalStatusOfSupplies

-Code
*Medicinal product subject to medical or veterinary prescription (B)

packaging

identifier: Global Trade Item Number/7680674310013

type: Box

quantity: 1

ShelfLifeStorages

-TypeSpecialPrecautionsForStorage
*Shelf life of the medicinal product as packaged for saleDo not store above 30°C
" }, "identifier" : [{ "system" : "http://fhir.ch/ig/ch-epl/sid/pcid", "value" : "CH-01100828-0674310010000-0001" }], "packageFor" : [{ "reference" : "MedicinalProductDefinition/Triogen-250mg-Capsule" }], "containedItemQuantity" : [{ "value" : 100, "unit" : "Capsule", "system" : "http://standardterms.edqm.eu", "code" : "15012000" }], "description" : "TRIOGEN Kaps 250 mg Ds 100 Stk", "legalStatusOfSupply" : [{ "code" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-legal-status-of-supply", "code" : "756005022003", "display" : "Medicinal product subject to medical or veterinary prescription (B)" }] } }], "packaging" : { "identifier" : [{ "system" : "urn:oid:2.51.1.1", "value" : "7680674310013" }], "type" : { "coding" : [{ "system" : "http://standardterms.edqm.eu", "code" : "30009000", "display" : "Box" }] }, "quantity" : 1, "shelfLifeStorage" : [{ "type" : { "coding" : [{ "system" : "http://spor.ema.europa.eu/v1/lists/100000073343", "code" : "100000073403", "display" : "Shelf life of the medicinal product as packaged for sale" }] }, "specialPrecautionsForStorage" : [{ "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-special-precautions-for-storage", "code" : "756005042009", "display" : "Do not store above 30°C" }] }] }] } } }, { "fullUrl" : "http://fhir.epl.bag.admin.ch/CHIDMP/RegulatedAuthorization/MA-67431001", "resource" : { "resourceType" : "RegulatedAuthorization", "id" : "MA-67431001", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-regulatedauthorization"] }, "text" : { "status" : "generated", "div" : "

Generated Narrative: RegulatedAuthorization MA-67431001

Profile: RegulatedAuthorization

identifier: Marketing Authorisation Number/67431001

subject: MedicinalProductDefinition: extension = Capsule, hard; identifier = http://fhir.ch/ig/ch-epl/sid/mpid#Medical Product Identifier#CH-01100828-0674310010000; indication = Zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Authorised for the treatment in children; classification = trientine,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product,07. STOFFWECHSEL,07.99. Varia

type: Marketing Authorisation

region: Switzerland

status: valid

statusDate: 2020-05-28

holder: Organization IDEOGEN AG

regulator: Organization Swissmedic Swiss Agency for Therapeutic Products

Generated Narrative: Organization #holder-Ideogen-AG

Profile: Organization

identifier: Swissmedic Location Identifier/01100828, LOC Identifier/100012910, GLN Identifier/7601001403062

name: IDEOGEN AG

Generated Narrative: Organization #regulator-SMC

Profile: Organization

identifier: LOC Identifier/100010911, GLN Identifier/7601001398511

name: Swissmedic Swiss Agency for Therapeutic Products

" }, "contained" : [{ "resourceType" : "Organization", "id" : "holder-Ideogen-AG", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-organization"] }, "identifier" : [{ "system" : "https://www.swissmedic.ch/fhir/identifier/locations", "value" : "01100828" }, { "system" : "https://spor.ema.europa.eu/v1/locations", "value" : "100012910" }, { "system" : "urn:oid:2.51.1.3", "value" : "7601001403062" }], "name" : "IDEOGEN AG" }, { "resourceType" : "Organization", "id" : "regulator-SMC", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-organization"] }, "identifier" : [{ "system" : "https://spor.ema.europa.eu/v1/locations", "value" : "100010911" }, { "system" : "urn:oid:2.51.1.3", "value" : "7601001398511" }], "name" : "Swissmedic Swiss Agency for Therapeutic Products" }], "identifier" : [{ "system" : "http://fhir.ch/ig/ch-epl/sid/authno", "value" : "67431001" }], "subject" : [{ "reference" : "MedicinalProductDefinition/Triogen-250mg-Capsule" }], "type" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type", "code" : "756000002001", "display" : "Marketing Authorisation" }] }, "region" : [{ "coding" : [{ "system" : "urn:iso:std:iso:3166", "code" : "CH", "display" : "Switzerland" }] }], "status" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-status", "code" : "756005023007", "display" : "valid" }] }, "statusDate" : "2020-05-28", "holder" : { "reference" : "#holder-Ideogen-AG" }, "regulator" : { "reference" : "#regulator-SMC" } } }, { "fullUrl" : "http://fhir.epl.bag.admin.ch/CHIDMP/RegulatedAuthorization/FOPH-21070", "resource" : { "resourceType" : "RegulatedAuthorization", "id" : "FOPH-21070", "text" : { "status" : "extensions", "div" : "

Generated Narrative: RegulatedAuthorization FOPH-21070

CH EPL - Reimbursement SL

url

FOPHDossierNumber

value: FOPH Dossier Number/21070

url

status

value: Reimbursed

url

statusDate

value: 2020-09-01

url

listingStatus

value: Listed

url

listingPeriod

value: 2020-09-01 --> (ongoing)

url

firstListingDate

value: 2020-09-01

url

costShare

value: 10

url

gamme

value: Oral

value: CHF4,117.12 (CHF)

type: Ex-factory price

changeType: Price mutation at first listing

changeDate: 2020-09-01

url

CH EPL - Product Price

value: CHF4,470.40 (CHF)

type: Retail price

changeType: VAT-change

changeDate: 2024-01-01

url

CH EPL - Product Price

subject: PackagedProductDefinition: identifier = http://fhir.ch/ig/ch-epl/sid/pcid#Clinical Product Identifier#CH-01100828-0674310010000-0001; containedItemQuantity = 100 Capsule; description = TRIOGEN Kaps 250 mg Ds 100 Stk

type: Reimbursement SL

Indications

-ExtensionReference
*ClinicalUseDefinition: type = indication

holder: Organization IDEOGEN AG

Generated Narrative: Organization #holder-Ideogen-AG

Profile: Organization

identifier: Swissmedic Location Identifier/01100828, LOC Identifier/100012910, GLN Identifier/7601001403062

name: IDEOGEN AG

" }, "contained" : [{ "resourceType" : "Organization", "id" : "holder-Ideogen-AG", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-organization"] }, "identifier" : [{ "system" : "https://www.swissmedic.ch/fhir/identifier/locations", "value" : "01100828" }, { "system" : "https://spor.ema.europa.eu/v1/locations", "value" : "100012910" }, { "system" : "urn:oid:2.51.1.3", "value" : "7601001403062" }], "name" : "IDEOGEN AG" }], "extension" : [{ "extension" : [{ "url" : "FOPHDossierNumber", "valueIdentifier" : { "system" : "urn:oid:2.16.756.1", "value" : "21070" } }, { "url" : "status", "valueCodeableConcept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-reimbursement-status", "code" : "756001021001", "display" : "Reimbursed" }] } }, { "url" : "statusDate", "valueDate" : "2020-09-01" }, { "url" : "listingStatus", "valueCodeableConcept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-listing-status", "code" : "756001002001", "display" : "Listed" }] } }, { "url" : "listingPeriod", "valuePeriod" : { "start" : "2020-09-01" } }, { "url" : "firstListingDate", "valueDate" : "2020-09-01" }, { "url" : "costShare", "valueInteger" : 10 }, { "url" : "gamme", "valueCodeableConcept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-gamme", "code" : "756002004001", "display" : "Oral" }] } }, { "extension" : [{ "url" : "value", "valueMoney" : { "value" : 4117.12, "currency" : "CHF" } }, { "url" : "type", "valueCodeableConcept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-price-type", "code" : "756002005002", "display" : "Ex-factory price" }] } }, { "url" : "changeType", "valueCodeableConcept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-type-of-price-change", "code" : "756002006013", "display" : "Price mutation at first listing" }] } }, { "url" : "changeDate", "valueDate" : "2020-09-01" }], "url" : "http://fhir.ch/ig/ch-epl/StructureDefinition/productPrice" }, { "extension" : [{ "url" : "value", "valueMoney" : { "value" : 4470.4, "currency" : "CHF" } }, { "url" : "type", "valueCodeableConcept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-price-type", "code" : "756002005001", "display" : "Retail price" }] } }, { "url" : "changeType", "valueCodeableConcept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-type-of-price-change", "code" : "756002006008", "display" : "VAT-change" }] } }, { "url" : "changeDate", "valueDate" : "2024-01-01" }], "url" : "http://fhir.ch/ig/ch-epl/StructureDefinition/productPrice" }], "url" : "http://fhir.ch/ig/ch-epl/StructureDefinition/reimbursementSL" }], "subject" : [{ "reference" : "PackagedProductDefinition/PMP-Triogen-250mg-Capsule" }], "type" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-authorisation-type", "code" : "756000002003", "display" : "Reimbursement SL" }] }, "indication" : [{ "extension" : [{ "extension" : [{ "url" : "status", "valueCodeableConcept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-limitationstatus", "code" : "756002071001", "display" : "Limitation Reimbursed" }] } }, { "url" : "statusDate", "valueDate" : "2020-09-01" }, { "url" : "period", "valuePeriod" : { "start" : "2020-09-01" } }, { "url" : "firstLimitationDate", "valueDate" : "2020-09-01" }, { "url" : "limitationIndication", "valueReference" : { "reference" : "ClinicalUseDefinition/LIM-79886009-TRIOGEN" } }, { "extension" : [{ "url" : "value", "valueMoney" : { "value" : 4117.12, "currency" : "CHF" } }, { "url" : "type", "valueCodeableConcept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-price-type", "code" : "756002005002", "display" : "Ex-factory price" }] } }, { "url" : "changeType", "valueCodeableConcept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-type-of-price-change", "code" : "756002006010", "display" : "Price mutation after triennal review of pharmaceuticals" }] } }, { "url" : "changeDate", "valueDate" : "2020-09-01" }], "url" : "http://fhir.ch/ig/ch-epl/StructureDefinition/productPrice" }, { "extension" : [{ "url" : "value", "valueMoney" : { "value" : 4470.4, "currency" : "CHF" } }, { "url" : "type", "valueCodeableConcept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-price-type", "code" : "756002005001", "display" : "Retail price" }] } }, { "url" : "changeType", "valueCodeableConcept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-type-of-price-change", "code" : "756002006008", "display" : "VAT-change" }] } }, { "url" : "changeDate", "valueDate" : "2024-01-01" }], "url" : "http://fhir.ch/ig/ch-epl/StructureDefinition/productPrice" }], "url" : "http://fhir.ch/ig/ch-epl/StructureDefinition/regulatedAuthorization-limitation" }], "reference" : { "reference" : "ClinicalUseDefinition/IND-10061091" } }], "holder" : { "reference" : "#holder-Ideogen-AG" } } }, { "fullUrl" : "http://fhir.epl.bag.admin.ch/CHIDMP/ManufacturedItemDefinition/MI-Trientinum-250mg-Capsule", "resource" : { "resourceType" : "ManufacturedItemDefinition", "id" : "MI-Trientinum-250mg-Capsule", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-manufactureditemdefinition"] }, "text" : { "status" : "generated", "div" : "

Generated Narrative: ManufacturedItemDefinition MI-Trientinum-250mg-Capsule

Profile: ManufacturedItemDefinition

status: Active

manufacturedDoseForm: Capsule, hard

unitOfPresentation: Capsule

" }, "status" : "active", "manufacturedDoseForm" : { "coding" : [{ "system" : "http://standardterms.edqm.eu", "code" : "10210000", "display" : "Capsule, hard" }] }, "unitOfPresentation" : { "coding" : [{ "system" : "http://standardterms.edqm.eu", "code" : "15012000", "display" : "Capsule" }] } } }, { "fullUrl" : "http://fhir.epl.bag.admin.ch/CHIDMP/AdministrableProductDefinition/PhP-Trientinum-250mg-Capsule", "resource" : { "resourceType" : "AdministrableProductDefinition", "id" : "PhP-Trientinum-250mg-Capsule", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-administrableproductdefinition"] }, "text" : { "status" : "generated", "div" : "

Generated Narrative: AdministrableProductDefinition PhP-Trientinum-250mg-Capsule

Profile: AdministrableProductDefinition

status: Active

formOf: MedicinalProductDefinition: extension = Capsule, hard; identifier = http://fhir.ch/ig/ch-epl/sid/mpid#Medical Product Identifier#CH-01100828-0674310010000; indication = Zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Authorised for the treatment in children; classification = trientine,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product,07. STOFFWECHSEL,07.99. Varia

administrableDoseForm: Capsule, hard

unitOfPresentation: Capsule

RouteOfAdministrations

-Code
*Oral use
" }, "status" : "active", "formOf" : [{ "reference" : "MedicinalProductDefinition/Triogen-250mg-Capsule" }], "administrableDoseForm" : { "coding" : [{ "system" : "http://standardterms.edqm.eu", "code" : "10210000", "display" : "Capsule, hard" }] }, "unitOfPresentation" : { "coding" : [{ "system" : "http://standardterms.edqm.eu", "code" : "15012000", "display" : "Capsule" }] }, "routeOfAdministration" : [{ "code" : { "coding" : [{ "system" : "http://standardterms.edqm.eu", "code" : "20053000", "display" : "Oral use" }] } }] } }, { "fullUrl" : "http://fhir.epl.bag.admin.ch/CHIDMP/Ingredient/Trientinum250", "resource" : { "resourceType" : "Ingredient", "id" : "Trientinum250", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-ingredient"] }, "text" : { "status" : "generated", "div" : "

Generated Narrative: Ingredient Trientinum250

Profile: Ingredient

status: Active

for:

role: Active

substance

Codes

-Concept
*Trientine

Strengths

-Presentation[x]
*250 mg (Details: UCUM codemg = 'mg')/1 Capsule (Details: EDQM - Standard Terms code15012000 = 'Capsule')
" }, "status" : "active", "for" : [{ "reference" : "AdministrableProductDefinition/PhP-Trientinum-250mg-Capsule" }, { "reference" : "ManufacturedItemDefinition/MI-Trientinum-250mg-Capsule" }], "role" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-ingredient-role", "code" : "756005051001", "display" : "Active" }] }, "substance" : { "code" : { "concept" : { "coding" : [{ "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-substance", "code" : "SJ76Y07H5F", "display" : "Trientine" }] } }, "strength" : [{ "presentationRatio" : { "numerator" : { "value" : 250, "unit" : "mg", "system" : "http://unitsofmeasure.org", "code" : "mg" }, "denominator" : { "value" : 1, "unit" : "Capsule", "system" : "http://standardterms.edqm.eu", "code" : "15012000" } } }] } } }, { "fullUrl" : "http://fhir.epl.bag.admin.ch/CHIDMP/ClinicalUseDefinition/IND-10061091", "resource" : { "resourceType" : "ClinicalUseDefinition", "id" : "IND-10061091", "meta" : { "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-clinicalusedefinition-indication"] }, "text" : { "status" : "generated", "div" : "

Generated Narrative: ClinicalUseDefinition IND-10061091

Profile: ClinicalUseDefinition Indication

type: Indication

subject: MedicinalProductDefinition: extension = Film-coated tablet; identifier = http://fhir.ch/ig/ch-epl/sid/mpid#Medical Product Identifier#CH-01100726-0677190010000; indication = Cuprior wird angewendet zur Behandlung von Morbus Wilson bei Erwachsenen, Jugendlichen und Kindern im Alter von 5 Jahren oder älter mit Unverträglichkeit gegenüber einer D-Penicillamin-Therapie.; legalStatusOfSupply = Medicinal product subject to medical or veterinary prescription (B); additionalMonitoringIndicator = No Warning; pediatricUseIndicator = Authorised for the treatment in children; classification = gilteritinib,NA KAS art. 12 para. 5 TPLO,Synthetic,Originator product,07. STOFFWECHSEL,07.99. Varia

indication

DiseaseSymptomProcedures

-Concept
*Wilson's disease

IntendedEffects

-Concept
*therapeutic
" }, "type" : "indication", "subject" : [{ "reference" : "MedicinalProductDefinition/Cuprior-150mg-Filmcoatedtablet" }], "indication" : { "diseaseSymptomProcedure" : { "concept" : { "coding" : [{ "system" : "https://www.meddra.org", "code" : "10061091", "display" : "Wilson's disease" }] } }, "intendedEffect" : { "concept" : { "coding" : [{ "system" : "http://spor.ema.europa.eu/v1/lists/200000003186", "code" : "200000003194", "display" : "therapeutic" }] } } } } }, { "fullUrl" : "http://fhir.epl.bag.admin.ch/CHIDMP/ClinicalUseDefinition/LIM-79886009-TRIOGEN", "resource" : { "resourceType" : "ClinicalUseDefinition", "id" : "LIM-79886009-TRIOGEN", "text" : { "status" : "generated", "div" : "

Generated Narrative: ClinicalUseDefinition LIM-79886009-TRIOGEN

type: Indication

indication

DiseaseSymptomProcedures

-Concept
*TRIOGEN wird vergütet zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen. Die Behandlung muss von Gastroenterologen oder Hepatologen mit Erfahrung bei der Behandlung von Patienten mit Morbus Wilson initiiert und überwacht werden.

IntendedEffects

-Concept
*therapeutic
" }, "type" : "indication", "indication" : { "diseaseSymptomProcedure" : { "concept" : { "coding" : [{ "system" : "http://snomed.info/sct", "code" : "79886009", "display" : "Disorder of copper metabolism" }], "text" : "TRIOGEN wird vergütet zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen. Die Behandlung muss von Gastroenterologen oder Hepatologen mit Erfahrung bei der Behandlung von Patienten mit Morbus Wilson initiiert und überwacht werden." } }, "intendedEffect" : { "concept" : { "coding" : [{ "system" : "http://spor.ema.europa.eu/v1/lists/200000003186", "code" : "200000003194", "display" : "therapeutic" }] } } } } }] }